TrialFrontiers in immunology2023

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.

Astrid Z Johansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.